Obesity, Diabetes and Gastrointestinal Malignancy: The role of Metformin and other Anti-diabetic Therapy
<p>The association between Diabetes and cancer has been known for decades with obesity and insulin resistance being postulated as the main underlying risk factors for both disorders. With rise of the epidemic of obesity in the USA and around the globe, there has been a rise in diabetes that is...
Saved in:
Main Authors: | Michael Ashamalla (Author), Irini Youssef (Author), Mena Yacoub (Author), Apoorva Jayarangaiah (Author), Nikita Gupta (Author), Justina Ray (Author), Sadat Iqbal (Author), Regina Miller Joie Singh (Author), Samy I McFarlane (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Obesity, Diabetes and Metabolic Syndrome - Peertechz Publications,
2018-07-27.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metformin use and the Risk of Gastrointestinal Malignancies in Diabetic Populations: A Meta-Analysis
by: Gil Hevroni, et al.
Published: (2020) -
Obese chronic kidney disease diabetic's patients: Malignant tumours
by: Esparza Martín N, et al.
Published: (2017) -
Metformin: Beyond Diabetes
Published: (2020) -
Obesity, Diabetes, and Metabolic Syndrome
by: Ghada Welwel
Published: (2020) -
Gastrointestinal Malignancies: Screening, Diagnosis, and Treatment
Published: (2023)